Status:
RECRUITING
Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
Lead Sponsor:
Connecticut Children's Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Pediatric Cancer
Adolescent and Young Adult Cancer
Eligibility:
All Genders
15-25 years
Phase:
NA
Brief Summary
The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to im...
Detailed Description
To improve sexual and reproductive health communication between adolescent and young adult oncology patients and their clinicians, the Investigator will be developing and testing proof-of-concept of a...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Adolescent and Young Adult Oncology Patients
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Be aged 15-25 years old at time of enrollment.
- Have a cancer diagnosis and currently be on cancer-directed therapy with at least one of the following:
- Chemotherapy: any anticancer drug to treat the cancer diagnosis, including immunotherapy.
- Radiotherapy: any radiotherapy to treat the cancer diagnosis.
- Surgery: any surgery to remove cancer including partial of total resections. Biopsies are not considered surgery.
- Be greater than or equal to 2 months from diagnosis/initiation of therapy, whichever occurred later.
- Be able to speak and read English
- Have permission to participate from a member of the patient's primary oncology team.
- Provision to sign and date the consent/assent form.
- Active study participation of primary oncology clinician
- Patient must have primary oncology care at Connecticut Children's Center for Cancer \& Blood Disorders of Children's Hospital Los Angeles Cancer \& Blood Disease Institute
- Exclusion Criteria
- An individual who meets and of the following criteria will be excluded from participation in this study:
- Not currently on cancer-directed therapy.
- Unable to speak and read English.
- Insufficient cognitive functioning to complete study measures (as determined by a member of the patient's primary oncology team)
- Pediatric Oncology Clinicians
- 1\. Be a pediatric oncology physician, clinical fellow, or advanced practice provider (including nurse practitioners and physician assistants) that provides clinical care for AYA patients with cancer
Exclusion
Key Trial Info
Start Date :
February 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 29 2029
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06982066
Start Date
February 10 2025
End Date
June 29 2029
Last Update
August 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Connecticut Children's Medical Center
Hartford, Connecticut, United States, 06106